hyaluronoglucosaminidase has been researched along with losartan potassium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behrman, R; Cherney, B; Crescenzi, T; Fraser, B; Griffin, J; Hixon, D; Joneckis, C; Kozlowski, S; Rosenberg, A; Schrager, L; Shacter, E; Temple, R; Webber, K; Winkle, H; Woodcock, J | 1 |
| Artamonov, AV; Bekarev, AA; Chaikovskiy, AV; Dygai, AM; Gol'dberg, VE; Gurto, RV; Khrichkova, TY; Kinsht, DN; Madonov, PG; Markova, TS; Minakova, MY; Miroshnichenko, LA; Simanina, EV; Stavrova, LA; Udut, EV; Zhdanov, VV; Zyuz'kov, GN | 1 |
1 review(s) available for hyaluronoglucosaminidase and losartan potassium
| Article | Year |
|---|---|
The FDA's assessment of follow-on protein products: a historical perspective.
Topics: Albumins; Allergens; Calcitonin; Drug Approval; Epoetin Alfa; Erythropoietin; Hepatitis B Vaccines; Hyaluronoglucosaminidase; Proteins; Recombinant Proteins; United States; United States Food and Drug Administration | 2007 |
1 other study(ies) available for hyaluronoglucosaminidase and losartan potassium
| Article | Year |
|---|---|
Effect of hyaluronidase immobilized using electron-beam synthesis nanotechnology on sensitivity of progenitor cells to regulatory factors.
Topics: Animals; Bone Marrow Cells; Colony-Forming Units Assay; Enzymes, Immobilized; Erythropoietin; Fibroblast Growth Factors; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Hyaluronoglucosaminidase; Insulin; Liver; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred CBA; Nanotechnology; Stem Cell Factor; Tissue Culture Techniques | 2011 |